CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 2 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures II, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER
12,582,848
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
12,582,848
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,582,848
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9*
5.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
Based on 245,860,127 shares of the Issuer’s common stock issued and outstanding as of December January 8, 2014, as reported in the Issuer’s Registration Statement on Form S-3 filed with the Securities Exchange Commission (the “SEC”) on January 8, 2014.
|
CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 3 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital II, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER*
12,582,848
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
12,582,848
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,582,848
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
5.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
Based on 245,860,127 shares of the Issuer’s common stock issued and outstanding as of December January 8, 2014, as reported in the Issuer’s Registration Statement on Form S-3 filed with the SEC on January 8, 2014.
|
CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 4 of 9 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital II, LLC
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER*
12,582,848
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
12,582,848
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,582,848
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
5.1%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
Based on 245,860,127 shares of the Issuer’s common stock issued and outstanding as of December January 8, 2014, as reported in the Issuer’s Registration Statement on Form S-3 filed with the SEC on January 8, 2014.
|
CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 5 of 9 Pages
|
Item 1(a)
|
Name of Issuer:
Transenterix, Inc.
|
Item 1(b)
|
Address of Issuer’s Principal Executive Offices:
635 Davis Drive, Suite 300
Morrisville, NC 27560
|
Item 2(a)
|
Name of Person Filing:
Quaker BioVentures II, L.P.
Quaker BioVentures Capital II, L.P.
Quaker BioVentures Capital II, LLC
|
Item 2(b)
|
Address of Principal Business Office or, if none, Residence:
The address of the principal business office of each of the Reporting Persons is 2929 Arch Street, Cira Centre, Philadelphia, PA 19104-2868.
|
Item 2(c)
|
Citizenship:
Quaker BioVentures II, L.P. – Delaware
Quaker BioVentures Capital II, L.P. – Delaware
Quaker BioVentures Capital II, LLC – Delaware
|
Item 2(d)
|
Title of Class of Securities:
Common Stock, $0.001 par value per share
|
Item 2(e)
|
CUSIP Number:
89366M102
|
Item 3
|
Not applicable.
|
Item 4
|
Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
Quaker BioVentures II, L.P. – 12,582,848
Quaker BioVentures Capital II, L.P. – 12,582,848
Quaker BioVentures Capital II, LLC – 12,582,848
|
CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 6 of 9 Pages
|
(b) Percent of class:
Quaker BioVentures II, L.P. – 5.1%
Quaker BioVentures Capital II, L.P. – 5.1%
Quaker BioVentures Capital II, LLC – 5.1%
(c) Number of shares as to which the person has:
(i)Sole power to vote or to direct the vote
Quaker BioVentures II, L.P. – 0
Quaker BioVentures Capital II, L.P. – 0
Quaker BioVentures Capital II, LLC – 0
(ii)Shared power to vote or to direct the vote
Quaker BioVentures II, L.P. – 12,582,848
Quaker BioVentures Capital II, L.P. – 12,582,848
Quaker BioVentures Capital II, LLC – 12,582,848
(iii)Sole power to dispose or to direct the disposition of
Quaker BioVentures II, L.P. – 0
Quaker BioVentures Capital II, L.P. – 0
Quaker BioVentures Capital II, LLC – 0
(iv)Shared power to dispose or to direct the disposition of
Quaker BioVentures II, L.P. – 12,582,848
Quaker BioVentures Capital II, L.P. – 12,582,848
Quaker BioVentures Capital II, LLC – 12,582,848
Quaker BioVentures Capital II, L.P. is the general partner of Quaker BioVentures II, L.P., and Quaker BioVentures Capital II, LLC is the general partner of Quaker Capital L.P.
|
|
Item 5
|
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following o.
|
Item 6
|
Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
|
Item 7
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
|
CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 7 of 9 Pages
|
Item 8
|
Identification and Classification of Members of the Group.
Each of the Reporting Persons may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.
|
Item 9
|
Notice of Dissolution of Group.
Not applicable.
|
Item 10
|
Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 8 of 9 Pages
|
Date: February 13, 2014
|
QUAKER BIOVENTURES II, L.P.
By: Quaker BioVentures Capital II, L.P., its general partner
By: Quaker BioVentures Capital II, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
QUAKER BIOVENTURES CAPITAL II, L.P.
By: Quaker BioVentures Capital II, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
|
QUAKER BIOVENTURES CAPITAL II, LLC
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
CUSIP No. 89366M102
|
SCHEDULE 13G
|
Page 9 of 9 Pages
|
Date: February 13, 2014
|
QUAKER BIOVENTURES II, L.P.
By: Quaker BioVentures Capital II, L.P., its general partner
By: Quaker BioVentures Capital II, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
QUAKER BIOVENTURES CAPITAL II, L.P.
By: Quaker BioVentures Capital II, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
|
QUAKER BIOVENTURES CAPITAL II, LLC
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|